Dr Aaron Tong

Dr Aaron Tong graduated from the National University of Singapore in 2005. He completed his Nuclear Medicine AST and senior residency in 2014 and currently works as a Senior Consultant at the Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital. He serves in various professional committees and is the immediate past Chairman of the Chapter of Nuclear Medicine in the College of Radiologists, Academy of Medicine, Singapore.

Dr Tong has keen interest and takes an active role in various research and educational activities. He has published over 50 papers and also written several book chapters. He has given many lectures and talks, in particular on targeted radionuclide therapy using Y-90 microspheres in liver tumours.

• Fellow of the Academy of Medicine, Singapore 2015
• Master of Medicine (Internal Medicine), National University of Singapore 2011
• Member of the Royal College of Physicians (UK), 2010
• Bachelor of Medicine and Bachelor of Surgery, National University of Singapore 2005

• Chairman, Chapter of Nuclear Medicine, College of Radiologists, Academy of Medicine Singapore (2021 - 2025)
• Committee member, Advisory Committee for Nuclear Medicine (ACNM), Health Regulation Group, MOH (2024 – current)
• Committee member, Nuclear Medicine Residency Advisory Committee, Joint Committee on Specialist Training, MOH (2024 – current)

• Singapore General Hospital, Service Quality - Service with a Heart Award (2024)
• SingHealth Residency (RiSE Awards) - Outstanding Faculty (2022)
• SingHealth Duke-NUS RadSci ACP Education Award - Outstanding Faculty (2018)
• British Journal of Radiology - Best of BJR (2017)
• Singapore General Hospital ACTIVE Day 2017 – Fitness challenge (category: under 45yr, male): 1st runner-up
• Singapore General Hospital IQC - Silver Award (2016)
• SingHealth Residency (RiSE Awards) - Outstanding Resident (2014)
• Radiological Society of North America - RSNA Travel Award for Young Investigators in Molecular Imaging (2013)

​Clinical Trials

1. Site-PI: “18F-MISO PET guided dose escalation in nasopharyngeal carcinoma – a feasibility and planning study” sponsored by Terry Fox Foundation, 2016 ($69,000).
2. Principal Investigator: “Functional imaging with Gallium-68 DOTAPEPTDE PET/CT and 131I-metaiodobenzylguanidine (MIBG) in order to determine feasibility of  Peptide Receptor Radionuclide Therapy and MIBG therapy (combined therapy)  in neuroblastoma” by SingHealth Foundation, Singapore. Clinical Research Start-up Grant category 2015 ($24,000).

1. Chen K, Tong AKT, Moe FNN, Ng DCE, Lo RHG, Gogna A, Yan SX, Thang SP, Loke KSH, Venkatanarasimha NK, Huang HL, Too CW, Ong TSK, Yeo EX, Peh DYY, Ng AWY, Yang L, Chan WY, Chang JPE, Goh BKP, Toh HC, Chow PKH. The impact of radiation dose and tumour burden on outcomes in hepatocellular carcinoma: 11-year experience in a 413-patient cohort treated with yttrium-90 resin microsphere radioembolization. Liver Cancer. September 19, 2024. DOI: 10.1159/000541539
2. Sommat K, Tong AKT, Ong ALK, Hu J, Sin SY, Lam WWC, Xie W, Khor YM, Lim C, Lim TW, Selvarajan S, Wang F, Tan TWK, Wee JTS, Soong YL, Fong KW, Hennedige T, Hua TC. 18F-FMISO PET-guided dose escalation with multifield optimization intensity-modulated proton therapy in nasopharyngeal carcinoma. Asi Pac J Clin Oncol. 2023 Oct;20(5): 611-619. PMID: 37157884
3. Loke KSH, Tham WY, Bharadwaj P, Keng FYJ, Huang Z, Idu M, Wong YM, Tan PKS, Zaheer S, Khor YM, Ng DCE, Wong WY, Tong AK. Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT). J Nucl Cardiol. 27:1005-1009 (2020)
4. Tong AK, Tham WY, Too CW, Tai DW, Chow PK, Ng DC. Molecular Imaging and Therapy of Liver Tumors. Seminars in Nuclear Medicine. 2020 Sept;50(5):419-433
5. Tham WY, Tong AKT, Loke KSH, Chio L, Lim GKY, Seah XY, Ng DCE, Yan SXX, Lam WWC. Divide and Conquer: Strategies in Singapore to manage a Nuclear Medicine Department During COVID-19. Journal of Nuclear Medicine Technology June 2020;48(2): 98-101
6. Tay WL, Chng CL, Tien CS, Loke KS, Lam WW, Fook-Chong SM, Tong AK. High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves' Disease. Ann Acad Med Singapore. 2019 Jun;48(6):181-187
7. Huang HL, Tong AKT, Thang SP, Yan SX, Lam WWC, Loke KSH, Tang CYL, Cheng LTJ, Ooi GSK, Low HC, Magsombol BM, Tham WY, Goh CXY, Tan CJ, Khor YM, Zaheer S, Bharadwaj P, Xie W, Ng DCE. Current status and Growth of Nuclear Theranostics in Singapore. Nucl Med Mol Imaging. 2019 Apr:53(2):96-101
8. Tay WL, Tong AKT, Hui KYD, Tang YLC, Chng CL. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort. Hell J Nucl Med. 2017 Sep-Dec;20(3):227-231
9. Tong AK, Kao YH, Too CW, Chin KF, Ng DC, Chow PK. Yttrium-90 hepatic radioembolization: Clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol. 2016 Jun; 89 (1062) : 20150943.
10. Tong AK, Zhang ZX, Zaheer S, Yan XS. Dual phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan. Clin Imag. 2016 May-Jun;40(3):486-491.
11. Rodríguez LS, Thang SP, Li H, Khor LK, Tay YS, Myint KO, Tong AK. A descriptive analysis of remnant activity during 90Y resin microspheres radioembolization of hepatic tumours: technical and dosimetric implications. Ann Nucl Med. 2016 Apr;30(3):255-261
12. Khor LK, Loi HY, Sinha AK, Tong KT, Goh BC, Loh KS, Lu SJ. 68Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma. Head Neck. 2016 Apr;38(4):E76-80
13. Tong AK, Neo HS, Kok TY. Disseminated lymphoma evolving into Neurolymphomatosis during Mid-cycle of chemotherapy detected by 18F FDG PET/CT. Ann Acad Med Singapore. 2015 Nov;44(11):545-7
14. Khor LK, Loi HY, Sinha AK, Tong KT, Goh BC, Loh KS, Lu SJ. Correlation between 68Ga-DOTA-NOC PET/CT and 18F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2015 June;42(7):1162-3.
15. Thang SP, Tong AK, Ng DC. Postmastectomy / Axillary node dissection chyloma: The additional value of SPECT/CT lymphoscintigraphy. J Breast Cancer. 2014 Sep;17(3):291-4.
16. Tong AK, Tan SY, Go YY, Lam WW. Cardiac structural abnormalities associated with IgG4-related coronary periarteritis and inflammation revealed by multimodality imaging. Can J Cardiol. 2014 Aug;30(8):956.e15-7.
17. Tong AK, Mann KP, Schuster DM, Yan X. A rare presentation of myocardial plasmacytoma assessed by FDG PET/CT. Clin Nucl Med. 2014 Jul;39(7):643-5.
18. Thang SP, Tong AK, Lam WW, Ng DC. SPECT/CT in Musculoskeletal Infections. Semin Musculoskelet Radiol. 2014 Apr;18(2):194-202.